117 related articles for article (PubMed ID: 30958661)
1. Benign Pleural Mesothelial Cells Have Higher Osmotic Water Permeability than Malignant Pleural Mesothelioma Cells and Differentially Respond to Hyperosmolality.
Katkova LE; Baturina GS; Bondar AA; Jagirdar RM; Hatzoglou C; Gourgoulianis KI; Solenov EI; Zarogiannis SG
Cell Physiol Biochem; 2019; 52(4):869-878. PubMed ID: 30958661
[TBL] [Abstract][Full Text] [Related]
2. Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.
Jagirdar RM; Apostolidou E; Molyvdas PA; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L489-95. PubMed ID: 26773069
[TBL] [Abstract][Full Text] [Related]
3. Effects of pharmacological primary cilium disturbance in the context of in vitro 2D and 3D malignant pleura mesothelioma.
Jagirdar RM; Pitaraki E; Kotsiou OS; Rouka E; Sinis SI; Varsamas C; Marnas P; Stergiopoulou E; Giannou A; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Biochem Biophys Res Commun; 2023 Apr; 654():128-135. PubMed ID: 36907140
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes.
Papazoglou ED; Jagirdar RM; Kouliou OA; Pitaraki E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569615
[TBL] [Abstract][Full Text] [Related]
5. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):854-61. PubMed ID: 23833051
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cells.
Kuramitsu Y; Tominaga W; Baron B; Tokuda K; Wang Y; Kitagawa T; Nakamura K
Anticancer Res; 2013 Jun; 33(6):2557-60. PubMed ID: 23749908
[TBL] [Abstract][Full Text] [Related]
7. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
Angelico G; Caltabiano R; Loreto C; Ieni A; Tuccari G; Ledda C; Rapisarda V
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495596
[TBL] [Abstract][Full Text] [Related]
9. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
10. M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo.
Chaouche-Mazouni S; Copin MC; Lassalle P; Lebaili N; Cortot A; Scherpereel A
In Vivo; 2013; 27(2):227-32. PubMed ID: 23422483
[TBL] [Abstract][Full Text] [Related]
11. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
13. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
Cury PM; Butcher DN; Corrin B; Nicholson AG
J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
[TBL] [Abstract][Full Text] [Related]
14. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Tsuji S; Tsuura Y; Morohoshi T; Shinohara T; Oshita F; Yamada K; Kameda Y; Ohtsu T; Nakamura Y; Miyagi Y
Br J Cancer; 2010 Aug; 103(4):517-23. PubMed ID: 20628387
[TBL] [Abstract][Full Text] [Related]
15. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
16. Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications.
Tsolaki V; Zarogiannis S; Zygoulis P; Kalomenidis I; Jagirdar R; Makris D; Daniil Z; Magkouta S; Triantafyllou I; Papanikolaou J; Gourgoulianis KI; Zakynthinos E
Respirology; 2020 Oct; 25(10):1060-1065. PubMed ID: 32124515
[TBL] [Abstract][Full Text] [Related]
17. Pathological and molecular biological approaches to early mesothelioma.
Tsujimura T; Torii I; Sato A; Song M; Fukuoka K; Hasegawa S; Nakano T
Int J Clin Oncol; 2012 Feb; 17(1):40-7. PubMed ID: 22237727
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Aquaporin-1 in lung adenocarcinomas and pleural mesotheliomas.
López-Campos JL; Sánchez Silva R; Gómez Izquierdo L; Márquez E; Ortega Ruiz F; Cejudo P; Barrot Cortés E; Toledo Aral JJ; Echevarría M
Histol Histopathol; 2011 Apr; 26(4):451-9. PubMed ID: 21360438
[TBL] [Abstract][Full Text] [Related]
20. Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.
Hiroshima K; Wu D; Hasegawa M; Koh E; Sekine Y; Ozaki D; Yusa T; Walts AE; Marchevsky AM; Nabeshima K; Tada Y; Shimada H; Tagawa M
Diagn Cytopathol; 2016 Jul; 44(7):591-8. PubMed ID: 27079839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
